eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | infective endocarditis |
| Symptom | C0004610|bacteremia |
| Sentences | 11 |
| PubMedID- 26060492 | The longer time bacteremia can lead to bacterial endocarditis in some high-risk or moderate-risk patients. |
| PubMedID- 24750901 | Vgs cause a wide range of infections in humans, including bacteremia inpatients with neutropenia, infective endocarditis, and orbital cellulitis (2–5).however, despite the substantial clinical effect of vgs, the epidemiology and pathogenesis of thesebacteria are minimally understood (6). |
| PubMedID- 25887177 | Identified an unknown focus of infection as one of several independent risk factors for infective endocarditis in patients with staphylococcus aureus bacteremia, and only 29.8% of our patients with unknown focus were examined with echocardiography. |
| PubMedID- 26184852 | Saprophyticus with the use of 16s rrna gene sequence analysis and maldi-tof ms (matrix-assisted laser desorption ionization time of flight mass spectrometry), indicating strongly that the intermittent catheterization-associated urinary tract infection resulted in bacteremia that eventually lead to infective endocarditis. |
| PubMedID- 20462352 | Aureus bacteremia, with or without infective endocarditis, who received intravenous daptomycin (6 mg/kg daily) and in whom pharmacokinetic data were collected were evaluated. |
| PubMedID- 20300418 | persistent bacteremia was independently associated with mrsa-infective endocarditis. |
| PubMedID- 23551389 | Bovis bacteremia were identified, of whom 10 with infective endocarditis (ie) underwent colonoscopic evaluation. |
| PubMedID- 24529852 | Risk factors associated with in-hospital mortality included a pittsburgh bacteremia score of 2 or greater, infective endocarditis, and end-stage renal disease. |
| PubMedID- 23988021 | Staphylococcus aureus is a major cause of bacteremia which frequently leads to infective endocarditis, metastatic abscess formation, toxic shock syndrome, gastroenteritis, pneumonia, osteomyelitis and septic arthritis (sa) 1. |
| PubMedID- 23866912 | Daptomycin is a bactericidal cyclic lipopeptide approved by the fda for the management of complicated skin and skin structure infections caused by susceptible isolates of a variety of gram-positive bacteria, including methicillin-resistant staphylococcus aureus, and for the management of bacteremia, including that associated with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates of s. aureus. |
| PubMedID- 21163728 | Combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms; and (2) s. aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates. |
Page: 1